Mechanisms of Candida Resistance to Antimycotics and Promising Ways to Overcome It: The Role of Probiotics.
Konstantin A DeminAleksandr G RefeldAnna A BogdanovaEvgeniya V PrazdnovaIgor Vitalievich PopovOlga Yurievna KutsevalovaAlexey Mikhailovich ErmakovAnzhelica B BrenDmitry V RudoyVladimir Anatolievich ChistyakovRichard WeeksMichael Leonidas ChikindasPublished in: Probiotics and antimicrobial proteins (2021)
Pathogenic Candida and infections caused by those species are now considered as a serious threat to public health. The treatment of candidiasis is significantly complicated by the increasing resistance of pathogenic strains to current treatments and the stagnant development of new antimycotic drugs. Many species, such as Candida auris, have a wide range of resistance mechanisms. Among the currently used synthetic and semi-synthetic antifungal drugs, the most effective are azoles, echinocandins, polyenes, nucleotide analogs, and their combinations. However, the use of probiotic microorganisms and/or the compounds they produce is quite promising, although underestimated by modern pharmacology, to control the spread of pathogenic Candida species.